In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has ...

Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws, and gave ...

Regeneron Pharmaceuticals secured a victory in an antitrust case that accused Amgen Inc. of anticompetitive bundling ...

Led by positive momentum for shares of Cisco and Amgen, the Dow Jones Industrial Average is climbing Thursday afternoon. Shares of Cisco and Amgen have contributed to the blue-chip gauge's intraday ...

It’s been 19 months since Amgen completed its $27.8 billion acquisition of Horizon Therapeutics, and the California company ...

The Dow Jones Industrial Average is falling Wednesday morning with shares of Amgen and 3M delivering the stiffest headwinds for the blue-chip average. The Dow was most recently trading 115 points ...

Regeneron's lead counsel was Jonathan D. Polkes of White & Case LLP.

Dow rises as Cisco and Amgen rally, but UnitedHealth drags after DOJ probe. Inflation cools, retail sales steady. Outlook ...

Shares of Amgen Inc. AMGN slipped 1.37% to $272.05 Thursday, on what proved to be an all-around positive trading session for ...

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

Deep-pocketed investors have adopted a bearish approach towards Amgen AMGN, and it's something market players shouldn't ...